Estradiol valerate/norethisterone enantate
| Combination of | |
|---|---|
| Estradiol valerate | Estrogen |
| Norethisterone enantate | Progestogen |
| Clinical data | |
| Trade names | Mesigyna, others |
| Other names | EV/NETE; HRP-102 |
| Routes of administration | Intramuscular injection |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| UNII | |
Estradiol valerate/norethisterone enantate (EV/NETE), sold under the brand name Mesigyna among others, is a form of combined injectable birth control which is used to prevent pregnancy in women. It contains estradiol valerate (EV), an estrogen, and norethisterone enantate (NETE), a progestin. The medication is given once a month by injection into muscle.
EV/NETE is approved for use in at least 36 countries, and is the most widely used combined injectable contraceptive. It is available widely throughout Latin America, in a few Asian and African countries, and in Turkey.